ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,215.59
-0.38%
Dow Jones
38,296.66
0.49%
US Dollar vs MXN
16.9824
-0.16%
Brent Oil
81.24
-0.87%
Bitcoin
67,266.00
-1.60%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IMARA Inc (IMRA)

  7. IMARA Inc (IMRA) Noticias

IMRA

IMARA (IMRA)

IMARA Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IMRA
FechaHoraFuenteTítuloSímboloCompañía
23/02/202315:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMRAIMARA Inc
22/02/202315:51Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:IMRAIMARA Inc
22/02/202315:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMRAIMARA Inc
22/02/202315:01GlobeNewswire Inc.Imara Announces Stockholder Approval of Merger With EnlivenNASDAQ:IMRAIMARA Inc
21/02/202315:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMRAIMARA Inc
21/02/202315:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMRAIMARA Inc
10/02/202315:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IMRAIMARA Inc
09/01/202305:02Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:IMRAIMARA Inc
16/11/202205:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IMRAIMARA Inc
10/11/202215:29Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:IMRAIMARA Inc
25/10/202215:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMRAIMARA Inc
24/10/202215:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMRAIMARA Inc
14/10/202211:13TipRanksImara Merging With Enliven, Shares PopNASDAQ:IMRAIMARA Inc
14/10/202205:31TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Crinetics Pharmaceuticals (CRNX) and IMARA (IMRA)NASDAQ:IMRAIMARA Inc
13/10/202215:35GlobeNewswire Inc.Enliven Therapeutics and Imara Announce Merger AgreementNASDAQ:IMRAIMARA Inc
07/10/202216:11Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:IMRAIMARA Inc
07/09/202208:05TipRanksIMARA (IMRA) Gets a Hold from H.C. WainwrightNASDAQ:IMRAIMARA Inc
07/09/202205:53Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IMRAIMARA Inc
05/08/202204:10TipRanksIMARA (IMRA) Receives a Hold from H.C. WainwrightNASDAQ:IMRAIMARA Inc
10/06/202205:15TipRanksAnalysts Conflicted on These Healthcare Names: Blueprint Medicines (BPMC) and IMARA (IMRA)NASDAQ:IMRAIMARA Inc
24/05/202216:12Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMRAIMARA Inc
05/04/202205:45GlobeNewswire Inc.Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-ThalassemiaNASDAQ:IMRAIMARA Inc
15/03/202215:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMRAIMARA Inc
15/03/202206:38Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMRAIMARA Inc
15/03/202206:00GlobeNewswire Inc.Imara Reports Full Year 2021 Financial Results and Business HighlightsNASDAQ:IMRAIMARA Inc
08/03/202206:00GlobeNewswire Inc.Imara to Webcast Conference Call of Full Year 2021 Financial Results and Business HighlightsNASDAQ:IMRAIMARA Inc
10/02/202206:00GlobeNewswire Inc.Imara to Present at 11th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:IMRAIMARA Inc
25/01/202207:07Dow Jones NewsImara Gets FDA Approval for Tovinontrine IND ApplicationNASDAQ:IMRAIMARA Inc
25/01/202206:00GlobeNewswire Inc.Imara Announces FDA Clearance of Investigational New Drug Application (IND) for Tovinontrine (IMR-687) for Heart Failure with Preserved Ejection Fraction (HFpEF)NASDAQ:IMRAIMARA Inc
06/01/202210:29TipRanksIMARA (IMRA) Gets a Hold Rating from Morgan StanleyNASDAQ:IMRAIMARA Inc
 Showing the most relevant articles for your search:NASDAQ:IMRA

Su Consulta Reciente

USOTC
GLLOF
Galileo Japan (GM)
BIT
1M
Manz Automation Ag Npv
EU
SWP
Sword
EU
3LNI
Graniteshares Financial ...
USOTC
GNRGF
General Copper Gold (PK)
HITB
DRPUETH
DRP Utility
TG
EQN2
Equinix
EU
FLUX
Fluxys Belgium
BIT
P1UYB7
NLBNPIT1UYB7 20351221 8....
NASDAQ
HCDIZ
Harbor Custom Development
LSE
40MK
Quadgas 3.07%
LSE
84JL
Bank Of Amr. 38
TG
HP2A
HSBC Securities Services...
BIT
P1VJG5
NLBNPIT1VJG5 20991231 36...
LSE
61WI
Anz Bank 2043
EU
RBBR
Bretagne Bretagne0%26aug24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados